School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

ABVC BIOPHARMA, INC. ABVC

Healthcare · Biotechnology

$1.00last close 2026-10-09 · market cap $26.69M · delayed data

Trailing returns

1M+3.09%
3M-31.03%
6M-30.07%
1Y-69.60%
5Y-95.37%

Basis: Adjusted daily closes.

What it does

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States.

Open ABVC in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies